Sep 8, 2026 05:00PM
Aug 13, 2026 04:00PM
May 14, 2026 04:06PM
May 14, 2026 04:00PM
May 12, 2026 06:00PM
Mar 26, 2026 04:00PM
Mar 24, 2026 05:00PM CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026
Mar 10, 2026 05:00PM
Dec 22, 2025 07:00PM
Nov 13, 2025 06:20PM
Nov 13, 2025 04:00PM
Nov 10, 2025 06:15PM
Aug 13, 2025 06:29PM
Aug 13, 2025 04:00PM CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
Aug 8, 2025 05:00PM
Jun 23, 2025 08:00PM
May 14, 2025 06:38PM
May 14, 2025 04:00PM
May 9, 2025 06:30PM
Mar 27, 2025 09:00AM
Mar 20, 2025 04:30PM CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
Nov 21, 2024 04:34PM
Nov 21, 2024 04:30PM
Nov 14, 2024 04:44PM
Nov 14, 2024 09:00AM
Nov 8, 2024 09:00AM
Aug 13, 2024 09:05AM
Aug 13, 2024 09:00AM CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
Aug 7, 2024 09:00AM
May 14, 2024 09:04AM
May 14, 2024 09:00AM
May 14, 2024 05:41AM
May 13, 2024 07:35PM
May 8, 2024 09:00AM
Mar 28, 2024 09:00AM CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
Mar 21, 2024 09:00AM
Nov 14, 2023 09:00AM
Nov 9, 2023 09:00AM
Aug 14, 2023 09:00AM
Aug 1, 2023 09:00AM
May 15, 2023 09:08AM
May 15, 2023 09:00AM CV Sciences, Inc. Reports First Quarter 2023 Financial Results
May 9, 2023 09:00AM
Apr 3, 2023 10:00AM
Mar 29, 2023 09:03AM
Mar 29, 2023 09:00AM
Mar 24, 2023 08:00PM
Mar 23, 2023 10:01AM
Mar 23, 2023 10:00AM CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction
Mar 21, 2023 10:00AM

1,224,171 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All